Discover the full insider trade history of Rapport Therapeutics, Inc., a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 19 May 2025 (Cession). Among the most active insiders: Bredt David. The full history is openly available.
10
Insider Decl.
0
Thresholds
€223,771
3 ops.
Buy Volume
€229,543
3 ops.
Sell Volume
43Σ signal
Buys €223,771€229,543 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.